University of Pittsburgh Clinical and Translational Science Institute
匹兹堡大学临床与转化科学研究所
基本信息
- 批准号:7485627
- 负责人:
- 金额:$ 440.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:ClinicalClinical ResearchCommitCommunitiesCommunity HealthDevelopmentDisciplineEnvironmentGoalsHealthHealth SciencesHealthcare SystemsHome environmentIndividualInformaticsInstitutesInstitutionInterdisciplinary StudyKnowledgeMedical centerParticipantPediatric HospitalsPennsylvaniaRangeResearchResearch TrainingResourcesRiskSECTM1 geneSchoolsScientistSiteStructureStudentsTraining ProgramsTranslatingTranslational ResearchUniversitiescancer Biomedical Informatics Gridhealth practicehigh schoolimprovedinnovationknowledge translationminority healthnovelpre-clinical researchprogramsresearch studytool
项目摘要
As one of the nation's leading academic research centers, the University of Pittsburgh has both an
opportunity and an obligation to take the inherent risks associated with reengineering a successful research
enterprise to undertake a transformative initiative that will result in the development and advancement of
clinical and translational science as a distinct discipline in western Pennsylvania. The University is committed
to transforming its culture, environment, and structure to achieve this goal by forming the Clinical and
Translational Science Institute (CTSI). The CTSI will serve as the integrative academic home for clinical and
translational scientists across the University's six health sciences schools; Carnegie Mellon University; the
University of Pittsburgh Medical Center (UPMC), one of the nation's largest and most financially successful
academic health care systems; and the region. The CTSI's primary focus is to develop, nurture, and support
a cadre of clinical and translational scientists by building on the University's existing clinical research training
programs (Roadmap K12, K30) to establish a comprehensive program with activities ranging from early
research exposure for high school students to advanced doctoral programs. Through "integration and
innovation," the CTSI will excel in the development of new biomedical knowledge and the translation of that
knowledge from the basic and preclinical research settings to individuals, communities, and health practice.
The Children's Hospital of Pittsburgh's General Clinical Research Center (GCRC) and the four sites of the
University of Pittsburgh GCRC will be reengineered, integrated, and augmented by new CTSI communitybased
and minority health focused centers to develop efficient, accessible, and widely used participant and
clinical interaction resources. The CTSI Center for Clinical and Translational Informatics, which is developing
translational research informatics tools for the NCI Cancer Biomedical Informatics Grid Initiative, will infuse
informatics tools into the entire lifecycle of clinical research studies and develop an online collaborative
research community. Innovative interdisciplinary research initiatives will be developed through the ten CTSI
resource cores and translated to health practice via a novel CTSI community partnership program and
through centralization of UPMC's extensive clinical networks. The resulting transformations in the institution,
scientist, research, and health practice will improve health locally, regionally, and nationally.
作为美国领先的学术研究中心之一,匹兹堡大学都有
机会和承担与重新设计成功研究相关的固有风险的义务
企业实施一项变革性倡议,将导致发展和进步
宾夕法尼亚州西部的临床和转化科学是独特的学科。大学的承诺
改变其文化,环境和结构,以形成临床和
翻译科学研究所(CTSI)。 CTSI将作为临床和
该大学六所健康科学学校的转化科学家;卡内基·梅隆大学;这
匹兹堡大学医学中心(UPMC),美国最大,最大的成功之一
学术卫生保健系统;和该地区。 CTSI的主要重点是开发,培养和支持
建立大学现有临床研究培训的临床和转化科学家干部
计划(路线图K12,K30),以建立一个全面的计划,其活动从早期
高中生研究高级博士课程的研究。通过“集成和
创新,“ CTSI将在开发新的生物医学知识和翻译方面表现出色
从基本和临床前研究环境到个人,社区和健康实践的知识。
匹兹堡一般临床研究中心(GCRC)的儿童医院和四个地点
匹兹堡大学GCRC将由新的CTSI社区重新设计,整合和增强
以少数民族健康为中心,以发展高效,可访问和广泛使用的参与者和
临床相互作用资源。 CTSI临床和翻译信息学中心正在开发
NCI癌症生物医学信息学网格计划的转化研究信息学工具将注入
信息学工具进入临床研究的整个生命周期,并开发在线协作
研究社区。创新的跨学科研究计划将通过十个CTSI制定
资源核心,并通过新颖的CTSI社区合作计划转化为健康实践,并将其转化为
通过集中化UPMC广泛的临床网络。机构的最终转变,
科学家,研究和健康实践将在本地,地区和全国改善健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN E REIS其他文献
STEVEN E REIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN E REIS', 18)}}的其他基金
ENACT: Translating Health Informatics Tools to Research and Clinical Decision Making
ENACT:将健康信息学工具转化为研究和临床决策
- 批准号:
10673622 - 财政年份:2022
- 资助金额:
$ 440.04万 - 项目类别:
ENACT: Translating Health Informatics Tools to Research and Clinical Decision Making
ENACT:将健康信息学工具转化为研究和临床决策
- 批准号:
10435620 - 财政年份:2022
- 资助金额:
$ 440.04万 - 项目类别:
University of Pittsburgh Clinical and Translational Science Institute
匹兹堡大学临床与转化科学研究所
- 批准号:
10216856 - 财政年份:2020
- 资助金额:
$ 440.04万 - 项目类别:
University of Pittsburgh Clinical and Translational Science Institute
匹兹堡大学临床与转化科学研究所
- 批准号:
10267454 - 财政年份:2020
- 资助金额:
$ 440.04万 - 项目类别:
University of Pittsburgh Clinical and Translational Science Institute
匹兹堡大学临床与转化科学研究所
- 批准号:
10642831 - 财政年份:2016
- 资助金额:
$ 440.04万 - 项目类别:
University of Pittsburgh Clinical and Translational Science Institute
匹兹堡大学临床与转化科学研究所
- 批准号:
9339795 - 财政年份:2016
- 资助金额:
$ 440.04万 - 项目类别:
University of Pittsburgh Clinical and Translational Science Institute
匹兹堡大学临床与转化科学研究所
- 批准号:
10599474 - 财政年份:2016
- 资助金额:
$ 440.04万 - 项目类别:
相似国自然基金
应激颗粒新关键结构分子CSDE1介导液-液相分离发挥抗NSCLC作用的机制与临床研究
- 批准号:82373962
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
级联信号放大纳米质谱探针集的构建及其超灵敏定量检测体液中痕量活性致病菌的临床研究
- 批准号:22304085
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基因治疗纯合子家族性高胆固醇血症——一项原创新药AAV的研究者发起的临床研究(IIT)
- 批准号:82370456
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
IFNα诱导型靶向B7-H3的第四代CAR-T细胞治疗新技术的研制及其在胶质母细胞瘤中的探索性临床研究
- 批准号:82373842
- 批准年份:2023
- 资助金额:73.00 万元
- 项目类别:面上项目
静脉溶栓治疗无效的缺血性卒中早期使用替罗非班治疗的多中心、双盲、双模拟、随机对照临床研究
- 批准号:82371334
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 440.04万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 440.04万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 440.04万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 440.04万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 440.04万 - 项目类别: